about
Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicityClinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patientsPlasma beta 2 microglobulin as a means of predicting gentamicin serum concentrations.Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days.Tobramycin pharmacokinetics in very low birth weight infants.Incidence of potentially toxic concentrations of gentamicin in the neonate.Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.Evaluation of a new latex agglutination inhibition card test for determining serum gentamicin levelsInfluence of age on tobramycin pharmacokinetics in patients with normal renal function.Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infectionsGentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsComparison of radioimmunoassay and enzyme immunoassay methods in determining gentamicin pharmacokinetic parameters and dosages.Gentamicin in neonates at risk for sepsis - peak serum concentrations are not necessaryPharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).Accumulation pharmacokinetics of tobramycin.Pharmacology and efficacy of netilmicin.Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary diseaseGentamicin: use of a programmable calculator to determine dosages from pharmacokinetic data for individual patients.Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients.Therapeutic drug monitoring of aminoglycosides in neonates.Population Pharmacokinetics and Dosing Considerations for Gentamicin in Newborns with Suspected or Proven Sepsis Caused by Gram-Negative Bacteria.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature.Acute renal failure after high-dose antibiotic bone cement: case report and review of the literature.Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: Systematic Review.The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance.A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing.Drug-induced ototoxicity. Pathogenesis and prevention.Drug level monitoring in paediatric practice.Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.Patients' safety: is there a systemic release of gentamicin by gentamicin-coated tibia nails in clinical use?The current and future state of pharmacogenomics medical education in the USA.Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.Performance characteristics of bioassay, radioenzymatic assay, homogeneous enzyme immunoassay, and high-performance liquid chromatographic determination of serum gentamicin.Recording inpatient weight: implications for medicines administration.New antibiotics. New hopes and new problems.Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants.Bayesian pharmacokinetic analysis of a gentamicin nomogram in neonates: a retrospective studyNetilmicin treatment of complicated urinary tract infection in patients with renal function impairment.
P2860
Q28359459-4D59E585-C604-4A1A-97FF-69E53BFC9597Q28367851-1152B47D-0BB9-4671-A52D-DDA27B929A21Q33726319-D7BF1446-5955-4A53-AC67-28412CBA01D7Q34080768-CB71DDED-56D4-46F6-BE46-2792224EDF30Q34447121-1F332301-AFDC-419E-8D3A-BC8A35AABB3FQ35117551-43C8E7C6-D1BD-4173-8266-728DBE64890CQ35668521-8DDB75DF-C097-4645-B4B6-7F9718495160Q35670076-5AB6DA11-89BA-459A-874B-05E261073AEDQ35671955-765E8734-47CB-424B-836E-F31B80DF348EQ35673926-FDF903B8-B951-4DDE-9C8B-057001B679E7Q35674282-EDC92D7F-46C8-4932-A4B5-EC5140058466Q35714140-3C11F5F8-04FB-4878-A480-B5078A5B4C35Q35718455-8ABD54E4-63E9-4917-8136-D73B6C4512D0Q36051172-944767A5-9230-4A3C-A81F-8055895FE107Q36126934-6057631F-32B3-4E8C-A9AD-AE4665EF630FQ36468777-D11C11FA-6AFC-4D5C-A3DE-4BF96CF1CC2BQ36469912-7E0EAB5A-A08D-45D0-9A21-C5C9DEA220DCQ36483889-CD68CF59-96E5-4BF0-9F70-42F761259460Q36656388-8B6A25EA-3349-4FD5-A3EA-308792C872E9Q36933449-F2062A90-1EEC-4EB1-A14D-C42810CBE217Q37409465-F82F09BA-719D-4CE1-8D5C-E24A2F991846Q37538698-7F0254F2-C3C9-46AB-A3C9-0CEC685F6650Q38215682-25DDC25F-FD92-46F3-BE1D-9BF73706FC0EQ38239999-DD7BDDCD-D2DD-4816-9776-F0D79422DFDCQ38521816-E1AD3E10-2A85-434E-847D-98BBC79A3B29Q38596654-143C134D-6BF9-4795-BB8C-5BB2E93EE607Q38620778-B79413ED-654E-474C-9B20-BB799F169FFFQ38680501-678F9F93-985D-4D29-9DD0-474595D00B5FQ38742605-6F0973A9-A613-476A-9B02-BF862F87CAFFQ38914642-66D68966-9371-4B4B-A7FB-F27663D05A04Q39071799-18BF8CC0-5A92-4814-A35B-9469C2EFB57EQ39359403-35C22486-D482-4ACB-9AFC-29A1624ECBE6Q39554953-B0D0B2F2-7FA7-4527-9DD1-A61E88245066Q39598341-479A10E5-E0A4-41A7-9FD1-DA4183D8C73FQ39856291-E454822E-FB26-4A49-98A9-BDCBF420CAF4Q40107546-25D80151-2B88-47C8-8E62-DDEF621F4D0FQ40178076-A7882E62-2B85-4245-8E19-345554AA3A7EQ40326667-A1A5F75B-807F-4AEF-8AA9-1392A930AAA3Q40561487-48280CCF-7BE5-417F-A26D-5FC60D12B372Q40621050-BF317620-8B3E-41AA-A6DF-94A438739687
P2860
description
1975 nî lūn-bûn
@nan
1975 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Gentamicin blood levels: a guide to nephrotoxicity.
@ast
Gentamicin blood levels: a guide to nephrotoxicity.
@en
Gentamicin blood levels: a guide to nephrotoxicity.
@nl
type
label
Gentamicin blood levels: a guide to nephrotoxicity.
@ast
Gentamicin blood levels: a guide to nephrotoxicity.
@en
Gentamicin blood levels: a guide to nephrotoxicity.
@nl
prefLabel
Gentamicin blood levels: a guide to nephrotoxicity.
@ast
Gentamicin blood levels: a guide to nephrotoxicity.
@en
Gentamicin blood levels: a guide to nephrotoxicity.
@nl
P2093
P356
P1476
Gentamicin blood levels: a guide to nephrotoxicity.
@en
P2093
Anderson ET
Dahlgren JG
P356
10.1128/AAC.8.1.58
P407
P577
1975-07-01T00:00:00Z